University of Cambridge launches new investment scheme for start-upsCambridge is launching a new investment scheme that will help support new companies connected to the University. The new fund, a Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) fund, will enable individuals to invest in new companies, while benefitting from generous tax incentives. Cambridge is the first university to launch its own SEIS fund, and the first to combine the SEIS with the more established EIS. The fund will be managed by London-based investment firm Parkwalk Advisors, with investment advice provided by Cambridge Enterprise, the University’s commercialisation arm. Cambridge is Europe’s most productive technology cluster, having produced nine companies valued at more than $1 billion, and two (ARM and Autonomy) valued at more than $10 billion. The vast majority of the more than 1,500 companies in the cluster are connected to the University in some way: they are either based directly on University research, are founded or staffed by Cambridge graduates, or work collaboratively with University researchers to find solutions to business problems. The University has an excellent track record in spinning out successful companies: the current equity portfolio of 68 companies has raised more than £800 million in funding since 1995, representing a leverage of 75 times the University investment. “Cambridge has a key role to play in an innovation-led recovery in the UK,” said Professor Sir Leszek Borysiewicz, Vice-Chancellor of the University. “This fund will dramatically increase the University’s ability to spin out successful companies, and enables individuals to invest alongside institutional funds in order to maximise returns.” “Parkwalk Advisors is delighted to be able to assist the University of Cambridge in raising capital to fund investment in early stage companies in the Cambridge cluster and thereby leverage the high quality research conducted at the University,” said Alastair Kilgour, Founder, Parkwalk Advisors. The SEIS was announced by the Government in the 2012 Budget as part of its strategy for stimulating economic growth. In addition to providing individual income tax relief of 50% of the amount invested, any gains on shares held for three years under the scheme are free from capital gains tax (CGT). In addition, during the 2012/13 tax year, gains realised on other investments that would otherwise be liable to CGT will also be exempted from that CGT if they are reinvested in SEIS. The SEIS is an extension to the EIS, and together the schemes enable individual investors to work cohesively with institutional investors and spread their investment across a range of companies. “While our companies have been very successful in attracting funding once they are well-established, the lack of access to early-stage funding is a major concern for very young companies,” said Dr Anne Dobrée, Head of Seed Funds at Cambridge Enterprise. “This scheme is an excellent way for alumni and friends of the University to invest in Cambridge start-ups and be a part of the continued success of the Cambridge cluster.” The University is aiming to raise £1 million to establish the fund, which will work alongside existing University seed funds. Last year, Cambridge Enterprise reviewed 54 new business ideas and made 11 investments totalling £640,000.
-ENDS-For more information please contact: Sarah Collins, Cambridge Enterprise, University of Cambridge Tel: +44 (0)1223 760335 Mob: +44 (0)7500 883612 Email: Sarah.Collins@enterprise.cam.ac.uk Parkwalk Advisors Tel: +44 (0)20 7759 2285 Email: email@example.com For more details, please visit www.parkwalkadvisors.com Notes to editors: Past investments by the Cambridge Seed Funds include Solexa (acquired by Illumina in 2007 for $600 million), and Entropic (acquired by Microsoft in 1999). Current investments include BlueGnome and Horizon Discovery, two of the fastest-growing companies in the UK. Both companies recently received the Queen’s Award for Enterprise, the UK’s most prestigious business award. Other successful Cambridge companies with connections to the University include Ubisense and RealVNC. Cambridge Enterprise Limited is a wholly owned subsidiary of the University of Cambridge, responsible for the commercialisation of University intellectual property. Activities include management and licensing of intellectual property and patents, proof of concept funding and support for University staff and research groups wishing to provide expert advice or facilities to public and private sector organisations. Cambridge Enterprise provides access to angel and early stage capital through the Cambridge Enterprise Seed Funds and Cambridge Enterprise Venture Partners, and offers business planning, mentoring, and other related programmes. Over the past four years, income from licensing, consultancy and equity transactions exceeded £37 million, of which £30 million represents distributions to University departments and academics. www.enterprise.cam.ac.uk Parkwalk Advisors invests in, and raises capital for, innovative UK technology companies. The Firm manages a series of technology funds, which predominantly invest in companies spun out of UK Universities and other research-intensive institutions. The Parkwalk UK Technology EIS Funds offer individuals unique access to high calibre investments in British innovation. Parkwalk manages investments for HNWs, UHNWs, Family Offices and Wealth Managers, attracted by the quality of the companies, their provenance, and the substantial tax incentives associated with making these investments EIS compliant. Parkwalk invests in UK innovation and technology across the spectrum, from seed through to AIM listed securities, and has fully invested its first two Funds with the third Fund currently investing. Parkwalk’s portfolio can be viewed here.